E-LIB Suche - Ergebnisse für: Mehta-Shah, Neha

1

Nivolumab plus brentuximab vedotin for relapsed/refractory ..:

Zinzani, Pier Luigi ; Salles, Gilles ; Moskowitz, Alison J....
Blood Advances. 8 (2024) 10 - p. 2400-2404 , 2024

Link: https://doi.org/10.1182/..

2

Blinatumomab consolidation post–autologous stem cell transp..:

Ghobadi, Armin ; Foley, Nicole C. ; Cohen, Jared...
Blood Advances. 8 (2024) 3 - p. 513-522 , 2024

Link: https://doi.org/10.1182/..

3

SOHO State-of-the-Art Updates and Next Questions: Treatment..:

Burton, Jackson S. ; Foley, Nicole C. ; Mehta-Shah, Neha
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 2 - p. 65-76 , 2024

Link: https://doi.org/10.1016/..

4

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, ..:

Song, Yuqin ; Malpica, Luis ; Cai, Qingqing...
The Lancet Oncology. 25 (2024) 1 - p. 117-125 , 2024

Link: https://doi.org/10.1016/..

5

The CNS relapse in T-cell lymphoma index predicts CNS relap..:

Bhansali, Rahul S. ; Ellin, Fredrik ; Relander, Thomas...
Blood Advances. 8 (2024) 13 - p. 3507-3518 , 2024

Link: https://doi.org/10.1182/..

6

Duvelisib plus romidepsin in relapsed/refractory T cell lym..:

Horwitz, Steven M. ; Nirmal, Ajit J. ; Rahman, Jahan...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

7

Neoantigen landscape supports feasibility of personalized c..:

Ramirez, Cody A. ; Becker-Hapak, Michelle ; Singhal, Kartik...
Blood Advances. 8 (2024) 15 - p. 4035-4049 , 2024

Link: https://doi.org/10.1182/..

8

Phase I Study of Duvelisib Study for Cytokine Release Syndr..:

Slade, Michael ; Rettig, Michael P. ; Crees, Zachary D...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S118-S119 , 2024

Link: https://doi.org/10.1016/..

9

POSTER: TCL-054 A Multi-Institutional Prospective Cohort St..:

Foley, Nicole ; Russler-Germain, David ; Watkins, Marcus...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S213 , 2023

Link: https://doi.org/10.1016/..

10

Mutations associated with progression in follicular lymphom..:

Russler-Germain, David A. ; Krysiak, Kilannin ; Ramirez, Cody...
Blood Advances. 7 (2023) 18 - p. 5524-5539 , 2023

Link: https://doi.org/10.1182/..

11

Lacutamab in patients with mycosis fungoides: efficacy resu..:

Bagot, Martine ; Kim, Youn H ; Ortiz-Romero, Pablo L...
European Journal of Cancer. 190 (2023) - p. 113032 , 2023

Link: https://doi.org/10.1016/..

12

Ultra-Deep Sequencing Reveals the Mutational Landscape of C..:

Gomez, Felicia ; Fisk, Bryan ; McMichael, Joshua F....
Cancer Research Communications. 3 (2023) 11 - p. 2312-2330 , 2023

Link: https://doi.org/10.1158/..

13

Nivolumab combined with brentuximab vedotin for R/R primary..:

Zinzani, Pier Luigi ; Santoro, Armando ; Gritti, Giuseppe...
Blood Advances. 7 (2023) 18 - p. 5272-5280 , 2023

Link: https://doi.org/10.1182/..

14

Refractory mogamulizumab-associated rash responding to an o..:

Lama, Carine M. ; Hernandez-Rovira, Miguel A. ; Mehta-Shah, Neha..
JAAD Case Reports. 38 (2023) - p. 64-67 , 2023

Link: https://doi.org/10.1016/..

15

TCL-306 Quality of Life in Patients With Cutaneous T-Cell L..:

Akkad, Neha ; Musiek, Amy ; Jeffe, Donna..
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S469 , 2023

Link: https://doi.org/10.1016/..